Iterum Therapeutics：Iterum Therapeutics plc (ITRM) 股價、新聞、報價和過往記錄
Iterum Therapeutics plc (ITRM) 股價、新聞、報價和過往記錄
IterumprovidesupdatesfromtheFDA'sAntimicrobialDrugsAdvisoryCommitteemeetingonitsNDAfororalsulopenemtotreatadultwomenwithuUTI.。其他文章還包含有：「IterumTherapeuticsplc(ITRM)」、「IterumTherapeuticsplc(ITRM)StockPrice」、「IterumTherapeutics(ITRM)新聞動態」、「OurCompany」、「IterumTherapeuticsPlc(ITRM)」、「ITRM-IterumTherapeuticsplc」、「IterumTherapeutics(ITRM)」、「IterumTherapeuticsplcOrd...
查看更多 離開網站
Iterum Therapeutics plc (ITRM)
https://www.iterumtx.com
Iterum Therapeutics Limited is dedicated to developing significantly differentiated anti-infectives aimed at combatting MDR pathogens.
Iterum Therapeutics plc (ITRM) Stock Price
https://finance.yahoo.com
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, ...
Iterum Therapeutics (ITRM) 新聞動態
https://www.futunn.com
評級 · 地址： 九龍尖沙咀彌敦道96號地下 (尖沙咀港鐵站B1出口右行,TheONE封面). 營業時間： 星期一至六: 10:00 am - 9:00 pm · 地址： 荃灣沙咀道280地鋪 (大鴻輝中心對面).
Our Company
https://www.iterumtx.com
Headquartered in Dublin, Ireland, we are a clinical-stage pharmaceutical company dedicated to developing significantly differentiated anti-infectives.
Iterum Therapeutics Plc (ITRM)
https://invest.cnyes.com
鉅亨美股頻道提供你最完整的ITRM - Iterum Therapeutics Plc (ITRM)、美股公司資料、美股股票代號、美股新聞、股價走勢、技術線圖、財報分析、外資分析師評等、歷史 ...
ITRM-Iterum Therapeutics plc
https://www.moneydj.com
Iterum Therapeutics plc(ITRM.US)為一家愛爾蘭臨床階段的製藥公司，從事開發抗多重耐藥性(MDR)病原體的抗傳染劑。其產品Sulopenem為一種生物可利用的抗生素，涵蓋革蘭氏陽性 ...
Iterum Therapeutics (ITRM)
https://www.futunn.com
ITRM Iterum Therapeutics. 收盤價10/11 16:00 (美東). 0.9301. +0.0002 +0.02%. 總市值2111.78萬. 市盈率TTM-467. 最高價. 0.9523. 最低價. 0.9100. 成交量. 8.12萬股.
Iterum Therapeutics plc Ordinary Share (ITRM)
https://www.nasdaq.com
Discover real-time Iterum Therapeutics plc Ordinary Share (ITRM) stock prices, quotes, historical data, news, and Insights for informed trading and ...
Iterum Therapeutics plc
https://www.annualreports.com
Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives aimed at combatting the global ...